Walleye Trading’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
S
TCMG
MAM
OC
Walleye Trading's NVAX Position: Q2 2026 in Review
Walleye Trading increased its Novavax (NVAX) stake by 90% in Q2 2026, buying an estimated $323K and bringing the position to 76,190 shares worth $718K. The position accounts for ﹤0.01% of the portfolio, ranked #2482.
Walleye Trading first reported a position in NVAX in Q2 2015 and has held it in 17 quarters since. The position peaked at $1.16M in Q4 2025. 104 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.
- Walleye Trading held 76,190 shares of Novavax worth $718K as of Q2 2026.
- Walleye Trading bought 36,042 Novavax shares in Q2 2026, an estimated $323K.
- Novavax made up ﹤0.01% of Walleye Trading's portfolio in Q2 2026, its #2482 holding.
- Walleye Trading first reported a position in Novavax in Q2 2015 and has held it in 17 quarters since.
- Walleye Trading's Novavax position peaked at $1.16M in Q4 2025.
- 104 funds tracked by Wall St. Rank held Novavax as of Q2 2026.
Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.